The RAPCO randomized controlled trial program is the first to show better clinical outcomes in coronary artery bypass grafting (CABG) with radial artery (RA) grafting compared with grafts from both the right internal thoracic artery (RITA) and saphenous vein (SV), according to new results released Sunday.